The current valuation score of SNDL Inc is 9.41, ranking 23 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -46.71, which is -97.44% below the recent high of -1.20 and -4.93% above the recent low of -49.01.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.